267 related articles for article (PubMed ID: 15905589)
1. Role of fibrinogen-like protein 2 prothrombinase/fibroleukin in experimental and human allograft rejection.
Ning Q; Sun Y; Han M; Zhang L; Zhu C; Zhang W; Guo H; Li J; Yan W; Gong F; Chen Z; He W; Koscik C; Smith R; Gorczynski R; Levy G; Luo X
J Immunol; 2005 Jun; 174(11):7403-11. PubMed ID: 15905589
[TBL] [Abstract][Full Text] [Related]
2. The prothrombinase activity of FGL2 contributes to the pathogenesis of experimental arthritis.
Melnyk MC; Shalev I; Zhang J; Bartczak A; Gorczynski RM; Selzner N; Inman R; Marsden PA; Phillips MJ; Clark DA; Levy GA
Scand J Rheumatol; 2011; 40(4):269-78. PubMed ID: 21469939
[TBL] [Abstract][Full Text] [Related]
3. Endothelial induction of fgl2 contributes to thrombosis during acute vascular xenograft rejection.
Ghanekar A; Mendicino M; Liu H; He W; Liu M; Zhong R; Phillips MJ; Levy GA; Grant DR
J Immunol; 2004 May; 172(9):5693-701. PubMed ID: 15100314
[TBL] [Abstract][Full Text] [Related]
4. The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis.
Marsden PA; Ning Q; Fung LS; Luo X; Chen Y; Mendicino M; Ghanekar A; Scott JA; Miller T; Chan CW; Chan MW; He W; Gorczynski RM; Grant DR; Clark DA; Phillips MJ; Levy GA
J Clin Invest; 2003 Jul; 112(1):58-66. PubMed ID: 12840059
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen-like protein 2/fibroleukin induces long-term allograft survival in a rat model through regulatory B cells.
Bézie S; Picarda E; Tesson L; Renaudin K; Durand J; Ménoret S; Mérieau E; Chiffoleau E; Guillonneau C; Caron L; Anegon I
PLoS One; 2015; 10(3):e0119686. PubMed ID: 25763980
[TBL] [Abstract][Full Text] [Related]
6. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
7. The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts.
Urbanellis P; Shyu W; Khattar R; Wang J; Zakharova A; He W; Sadozai H; Amir AZ; Shalev I; Phillips MJ; Adeyi O; Ross H; Grant D; Levy GA; Chruscinski A
Immunology; 2015 Jan; 144(1):91-106. PubMed ID: 24990517
[TBL] [Abstract][Full Text] [Related]
8. [Expression of human fibrinogen-like protein 2/fibroleukin in renal acute allograft rejection and its potential clinical implication].
Zhang L; Ning Q; Guo H; Zhang WJ; Chen F; Luo XP
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):474-7. PubMed ID: 15061965
[TBL] [Abstract][Full Text] [Related]
9. The same immunoregulatory molecules contribute to successful pregnancy and transplantation.
Gorczynski RM; Hadidi S; Yu G; Clark DA
Am J Reprod Immunol; 2002 Jul; 48(1):18-26. PubMed ID: 12322892
[TBL] [Abstract][Full Text] [Related]
10. Novel mfgl2 antisense plasmid inhibits murine fgl2 expression and ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice.
Zhu C; Sun Y; Luo X; Yan W; Xi D; Ning Q
Hum Gene Ther; 2006 Jun; 17(6):589-600. PubMed ID: 16776568
[TBL] [Abstract][Full Text] [Related]
11. Intact type 1 immunity and immune-associated coagulative responses in mice lacking IFN gamma-inducible fibrinogen-like protein 2.
Hancock WW; Szaba FM; Berggren KN; Parent MA; Mullarky IK; Pearl J; Cooper AM; Ely KH; Woodland DL; Kim IJ; Blackman MA; Johnson LL; Smiley ST
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3005-10. PubMed ID: 14976252
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance.
Xie L; Ichimaru N; Morita M; Chen J; Zhu P; Wang J; Urbanellis P; Shalev I; Nagao S; Sugioka A; Zhong L; Nonomura N; Takahara S; Levy GA; Li XK
Liver Transpl; 2012 Apr; 18(4):444-54. PubMed ID: 22162188
[TBL] [Abstract][Full Text] [Related]
13. Kinetic analysis of a unique direct prothrombinase, fgl2, and identification of a serine residue critical for the prothrombinase activity.
Chan CW; Chan MW; Liu M; Fung L; Cole EH; Leibowitz JL; Marsden PA; Clark DA; Levy GA
J Immunol; 2002 May; 168(10):5170-7. PubMed ID: 11994472
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Fibrinogen-Like Protein 2 Promotes Tolerance in a Fully Mismatched Murine Model of Heart Transplantation.
Bartczak A; Chruscinski A; Mendicino M; Liu H; Zhang J; He W; Amir AZ; Nguyen A; Khattar R; Sadozai H; Lobe CG; Adeyi O; Phillips MJ; Zhang L; Gorczynski RM; Grant D; Levy GA
Am J Transplant; 2016 Jun; 16(6):1739-50. PubMed ID: 26718313
[TBL] [Abstract][Full Text] [Related]
15. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions.
Bishop DK; Chan Wood S; Eichwald EJ; Orosz CG
J Immunol; 2001 Mar; 166(5):3248-55. PubMed ID: 11207279
[TBL] [Abstract][Full Text] [Related]
16. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting.
Wang H; Hosiawa KA; Min W; Yang J; Zhang X; Garcia B; Ichim TE; Zhou D; Lian D; Kelvin DJ; Zhong R
J Immunol; 2003 Oct; 171(7):3823-36. PubMed ID: 14500684
[TBL] [Abstract][Full Text] [Related]
17. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
[TBL] [Abstract][Full Text] [Related]
18. Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells.
Chan CW; Kay LS; Khadaroo RG; Chan MW; Lakatoo S; Young KJ; Zhang L; Gorczynski RM; Cattral M; Rotstein O; Levy GA
J Immunol; 2003 Apr; 170(8):4036-44. PubMed ID: 12682232
[TBL] [Abstract][Full Text] [Related]
19. Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B.
Zhu CL; Yan WM; Zhu F; Zhu YF; Xi D; Tian DY; Levy G; Luo XP; Ning Q
World J Gastroenterol; 2005 Nov; 11(44):6936-40. PubMed ID: 16437596
[TBL] [Abstract][Full Text] [Related]
20. FGL2 prothrombinase contributes to the early stage of coronary microvascular obstruction through a fibrin-dependent pathway.
Li WZ; Yang Y; Liu K; Long R; Jin N; Huang SY; You Y; Dai J; Fan C; Wang J; Wang ZH
Int J Cardiol; 2019 Jan; 274():27-34. PubMed ID: 30279004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
